CortControl Received U.S. Patent for Fertility Enhancement
BY JAMES DANIELS, CEO, CORTCONTROL LLC
Recently, we at CortControl received some excellent news that we hope will soon be life-changing news for many couples experiencing infertility-related issues. The Directory of the U.S. Patent and Trademark Office has officially granted our company a patent for our fertility enhancement medical food Glutrasol™ FE.
Glutrasol FE supports fertility in both men and women that may result from high cortisol levels due to increased stress: a condition, which, according to Colette Bopuchez of WebMD, “may actually play a role in up to 30% of all infertility problems.” And, although Glutrasol FE is a relatively new product, it is based on chemistries that veterinarians have—for more than 40 years—found to be highly effective in increasing fertility rates in cattle and other livestock. In some cases, these fertility rates have increased by as much as 70%.
While there are numerous infertility treatments on the market, Glutrasol FE offers two distinctive benefits that both fertility specialists and patients will find extremely attractive. First, since Glutrasol FE is a specialty supplement that is ingested just like other foods, it is non-invasive. And second, as a specialty nutraceutical, it is far less expensive than in vitro fertilization and other fertility treatments that can cost many thousands of dollars. For these reasons, and because of its proven effectiveness with livestock, we believe that Glutrasol FE can be a sensible, low-cost initial treatment that effectively addresses infertility for many couples before specialists turn to more invasive and costly approaches.
For pharmaceutical companies and others interested in partnering with CortControl in the actual mass production, marketing, and distribution of Glutrasol FE, an enormous opportunity also exists. According to the Mayo Clinic, between 10% and 15% of all couples of childbearing age have difficulty either conceiving or taking a pregnancy through to term. In the U.S. alone, this represents tens of millions of couples—many of them potential Glutrasol FE users.
The vast majority of people look at having children as one of life’s great experiences. Sadly, though, problems with fertility create major challenges for a significant number of them. Glutasol FE, of course, is only one of numerous options people have when considering fertility support. But, for everyone with a stake in fertility support, it is also quite innovative and absolutely worth investigating.
Jim Daniels is the CEO and Co-founder of CortControl, an LLC that develops and markets the specialty nutraceutical Glutrasol FE for fertility and Glutrasol™ IE for immuno-enhancement. For more information about specialty supplements in general or Glutrasol FE in particular, please visit www.cortcontrol.com or contact Jim directly at Jim@cortcontrol.com.